For twenty years, the human immunodeficiency virus (HIV) has been thwarting the attempts of scientists to develop an effective vaccine. Scientists are seeing major promise in the latest batch, so much promise that major pharmaceutical company GlaxoSmithKline is making deals.
Ray of Hope Shines On Ebola Vaccine
Researchers in Canada and the US have moved a step closer in settling the scourge brought upon by two of the deadliest viruses known to man.
ERP System Aids Vaccine Developer
Major Government Contract for Smallpox Vaccine Spurs Need for Compliance, Control and Scale; Ross’ Proven Expertise Supports Rapid Development of Acambis’ Manufacturing Function.